News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19


 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

Booster recommendations for pregnant women, teens, and other groups explained
MDedge Emergency Medicine
Children and COVID: Weekly cases resume their climb
MDedge Emergency Medicine
COVID-19 asymptomatic infection rate remains high
MDedge Emergency Medicine
Even COVID-19 can’t stop a true optimist
MDedge Emergency Medicine
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
MDedge Emergency Medicine
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
MDedge Emergency Medicine
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
MDedge Emergency Medicine
Children and COVID: New cases up slightly, vaccinations continue to slow
MDedge Emergency Medicine
Bamlanivimab’s effects in COVID-19 depend on antibodies
MDedge Emergency Medicine
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
MDedge Emergency Medicine